MUMBAI: If the stock market had a hall of fame for patience, Biocon would deserve a shiny plaque. After two decades since its IPO debut in...
MUMBAI: Biocon Biologics Ltd has announced the US launch of Yesintek (ustekinumab-kfce), one of the first biosimilars to Janssen’s Stelara® to enter the American market. The...

This will close in 10 seconds